Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
All patients received WEGOVY injection during the run-in period of 20 weeks that included 16 weeks of dose escalation
Increase practice revenue with high-demand, cash-pay services
If you believe a patient is on the right drug, start at a lower dose, regardless of what they were previously taking
Critical Role of TFEB-mediated lysosomal biogenesis in alcohol-induced pancreatitis in mice and humans
Doug Langa, Novos executive vice president of North America Operations, told analysts on the Q2 earnings call that the company will continue to dynamically manage supply with the Wegovy initiation dose strength of .25 milligrams to ensure that patients who begin treatment can continue without disruption
